XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES AND SHAREHOLDERS'' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Convertible Common Shares
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings (Accumulated Deficit)
Balance at Dec. 31, 2020 $ 2,207,018   $ 20,765 $ 1,765,323 $ 33,516 $ 387,414
Balance, Shares at Dec. 31, 2020   3,787 166,123      
Net issuance of common stock under stock-based plans 322   $ 111 211    
Net issuance of common stock under stock-based plans (in shares)     885      
Stock-based compensation expense 25,874     25,874    
Repurchase of common stock $ (203,184)   $ (196)     (202,988)
Repurchase of common stock (in shares) 1,600   (1,564)      
Cash dividends $ (33,305)         (33,305)
Settlements of convertible notes 203,706   $ 199 203,507    
Settlement of convertible debt (in shares)     1,589      
Exercise of convertible notes hedge call options (205,213)   $ (199) (205,014)    
Exercise of convertible notes hedge call options (in shares)     (1,589)      
Convertible common shares (17,599)     (17,599)    
Convertible common shares (in shares)   17,599        
Net income 533,831         533,831
Other comprehensive income (loss) (18,194)       (18,194)  
Balance at Jul. 04, 2021 2,493,256   $ 20,680 1,772,302 15,322 684,952
Balance, Shares at Jul. 04, 2021   21,386 165,444      
Balance at Apr. 04, 2021 2,324,553   $ 20,802 1,765,971 8,677 529,103
Balance, Shares at Apr. 04, 2021   1,233 166,419      
Net issuance of common stock under stock-based plans 14,310   $ 27 14,283    
Net issuance of common stock under stock-based plans (in shares)     215      
Stock-based compensation expense 12,515     12,515    
Repurchase of common stock (155,995)   $ (149)     (155,846)
Repurchase of common stock (in shares)     (1,190)      
Cash dividends (16,624)         (16,624)
Settlements of convertible notes 46,023   $ 46 45,977    
Settlement of convertible debt (in shares)     367      
Exercise of convertible notes hedge call options (46,337)   $ (46) (46,291)    
Exercise of convertible notes hedge call options (in shares)     (367)      
Convertible common shares (20,153)     (20,153)    
Convertible common shares (in shares)   20,153        
Net income 328,319         328,319
Other comprehensive income (loss) 6,645       6,645  
Balance at Jul. 04, 2021 2,493,256   $ 20,680 1,772,302 15,322 684,952
Balance, Shares at Jul. 04, 2021   21,386 165,444      
Balance at Dec. 31, 2021 2,562,444   $ 20,281 1,811,545 (5,948) 736,566
Balance, Shares at Dec. 31, 2021   1,512 162,251      
Net issuance of common stock under stock-based plans (16,245)   $ 73 (16,318)    
Net issuance of common stock under stock-based plans (in shares)     585      
Stock-based compensation expense 25,862     25,862    
Repurchase of common stock $ (545,798)   $ (619)     (545,179)
Repurchase of common stock (in shares) 5,000   (4,956)      
Cash dividends $ (35,470)         (35,470)
Settlements of convertible notes (181)   $ 125 (306)    
Settlement of convertible debt (in shares)     1,004      
Exercise of convertible notes hedge call options 0   $ (125) 125    
Exercise of convertible notes hedge call options (in shares)     (1,004)      
Cumulative-effect of change in accounting principle related to convertible debt (4,720) $ (1,512)   (99,322)   94,602
Net income 359,715         359,715
Other comprehensive income (loss) (47,011)       (47,011)  
Balance at Jul. 03, 2022 2,298,596   $ 19,735 1,721,586 (52,959) 610,234
Balance, Shares at Jul. 03, 2022   0 157,880      
Balance at Apr. 03, 2022 2,474,532   $ 20,132 1,711,690 (19,479) 762,189
Balance, Shares at Apr. 03, 2022   0 161,053      
Net issuance of common stock under stock-based plans (1,671)   $ 4 (1,675)    
Net issuance of common stock under stock-based plans (in shares)     33      
Stock-based compensation expense 11,658     11,658    
Repurchase of common stock (334,334)   $ (401)     (333,933)
Repurchase of common stock (in shares)     (3,206)      
Cash dividends (17,561)         (17,561)
Settlements of convertible notes (87)   $ 62 (149)    
Settlement of convertible debt (in shares)     495      
Exercise of convertible notes hedge call options 0   $ (62) 62    
Exercise of convertible notes hedge call options (in shares)     (495)      
Cumulative-effect of change in accounting principle related to convertible debt 1,752         1,752
Net income 197,787         197,787
Other comprehensive income (loss) (33,480)       (33,480)  
Balance at Jul. 03, 2022 $ 2,298,596   $ 19,735 $ 1,721,586 $ (52,959) $ 610,234
Balance, Shares at Jul. 03, 2022   0 157,880